Glucocorticoids like dexamethasone are essential for managing various inflammatory and autoimmune conditions. However, their chronic administration often leads to significant muscle wasting. Recent research highlights how natural products muscle atrophy interventions can mitigate these debilitating side effects. Specifically, plant-derived compounds target the FoxO transcription factor to restore skeletal muscle homeostasis and function.

The Role of FoxO in Muscle Degradation

Steroid-induced muscle atrophy occurs through protein metabolism imbalance and mitochondrial dysfunction. The FoxO family of transcription factors serves as a central regulator in this process. When glucocorticoids activate FoxO, they trigger the expression of muscle-specific E3 ubiquitin ligases like MuRF1 and Atrogin-1. These enzymes accelerate protein breakdown, which results in a loss of muscle mass. Furthermore, FoxO modulation affects energy metabolism and autophagy pathways, exacerbating tissue damage.

How Natural Products Muscle Atrophy Strategies Work

Several signaling pathways, including Akt, AMPK, and SIRT, strictly regulate FoxO activity in the body. Plant monomer compounds such as flavonoids, polyphenols, and terpenes can effectively inhibit FoxO overactivation. By doing so, they prevent the excessive degradation of muscle fibers. These products also enhance mitochondrial health and reduce oxidative stress. Consequently, these natural agents provide a multi-targeted approach for preserving muscle health during glucocorticoid therapy.

Potential Candidates: Flavonoids and Terpenes

Evidence suggests that specific phytochemicals like quercetin, resveratrol, and various terpenes show remarkable myoprotective effects. These compounds improve the balance between protein synthesis and degradation. Moreover, they offer a safer profile compared to some synthetic alternatives. Integrating these plant-derived agents into clinical strategies could provide a more precise prevention method for patients at risk of steroid-induced sarcopenia.

Conclusion

Managing muscle wasting remains a major challenge for clinicians treating chronic inflammatory diseases. However, the modulation of FoxO activity by plant-derived natural products offers a promising therapeutic avenue. By incorporating these bioactive compounds, healthcare providers can better manage the musculoskeletal side effects of long-term steroid use.

FAQs

Can natural products muscle atrophy interventions replace physical therapy?

No, natural products should complement, not replace, standard interventions like resistance exercise and nutritional support. They work synergistically to enhance muscle recovery and prevent degradation.

Which natural compounds are most effective for FoxO modulation?

Research frequently highlights flavonoids (like quercetin), polyphenols (like resveratrol), and terpenes. These compounds inhibit FoxO-mediated protein breakdown by activating the Akt signaling pathway.

Are these plant-derived products clinically available in India?

Many of these compounds are available as nutraceuticals or are found in traditional AYUSH formulations. However, patients must use them under medical supervision to avoid potential interactions with prescribed steroids.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Dai W et al. Plant‑derived natural products alleviate dexamethasone‑induced skeletal muscle atrophy by modulating FoxO (Review). Int J Mol Med. 2026 Aug undefined. doi: undefined. PMID: 42246193.

2. Dabur R et al. Natural products: Potential therapeutic agents to prevent skeletal muscle atrophy. Eur J Pharmacol. 2022 Jun 15;925:174995. doi: 10.1016/j.ejphar.2022.174995.

3. Kim H et al. Myoprotective Role of Quercus acuta Thunb. Fruit Extract Through IGF-1–Akt–FOXO Axis Modulation in Dexamethasone-Induced Sarcopenia. Nutrients. 2025; 17(1):123. doi: 10.3390/nu17010123.

"